Access 2.8M+ Filings Sign Up Free
CHOSA Oncology AB Logo

CHOSA Oncology AB | CHOSA - Profile, Filings, Stock Info & Investor Relations Data

CHOSA Oncology AB | CHOSA
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Sweden
Founded
N/A
CHOSA Oncology AB (CHOSA)

Company Profile

Website
Investor Relations

About CHOSA Oncology AB

Chosa Oncology, Danish -Swedish biotechnology company, has developed the iCIP platform, which includes a liposomal formulation of cisplatin (LiPlaCis) and the companion diagnostic (DRP) tool detecting patients who benefits the most of the cisplatin treatment. The recently achieved clinical phase 2b results mean that the Company is now gearing up the business development activities to find partners for partnership or trade deal.

Headquarters

C/O Medicon Village, C/O Medicon Village, Scheeletorget 1
223 81, Lund
Sweden

CHOSA Oncology AB (CHOSA)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

CHOSA Oncology AB (CHOSA)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

CHOSA Oncology AB (CHOSA)
Stock & Investor Information

ISINs

SE0007784319

LEI

5493002SFL9YXB0A0027

Stock Exchange Listings

Spotlight Exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology